Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia

Yalçın, Cumali; Özkalemkaş, Fahir; Özkocaman, VİLDAN; Ersal, Tuba; Pınar, İbrahim; Orhan, Bedrettin; Candar, Ömer; Çubukçu, Sinem; Koca, Tuba; Akyol, Merve; Ada, Nevriye; Özakın, CÜNEYT; Kazak, ESRA; Akalın, EMİN; Ali, Rıdvan

doi:10.4084/mjhid.2022.039

Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia

Atıf İçin Kopyala

Yalçın C., Özkalemkaş F., Özkocaman V., Ersal T., Pınar İ. E., Orhan B., ...Daha Fazla

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, cilt.14, 2022 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14
Basım Tarihi: 2022
Doi Numarası: 10.4084/mjhid.2022.039
Dergi Adı: MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
Anahtar Kelimeler: Empiric glycopeptide, Febrile neutropenia, Hematologic malignancy, INFECTIOUS-DISEASES SOCIETY, BLOOD-STREAM INFECTIONS, ACUTE MYELOID-LEUKEMIA, CANCER-PATIENTS, MORTALITY, VANCOMYCIN, CHEMOTHERAPY, EPIDEMIOLOGY, MANAGEMENT, FREQUENCY
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: This study aimed to evaluate the effects of the appropriate use of empiric glycopeptide therapy in hematologic malignancy patients with febrile neutropenia (FN).